another great find. way to dig up the old stuff. Fun to see how the company's adapted with the evolving technology and how they've narrowed themselves into more practical avenues. wolfson sure has a sharp mind when he's talking on the fly like that. I like how the direction was well thought out - albeit, a bit naive as to where to first focus in light of our hindsight 20/20.
Incredible. Is wall street that dumb that they can't even get the food description right?? We don't include eggs and butter in our ingredients. ... we help replace them.
Somehow I think Ecover might be more bullish on SZYM than the stock-watching investors might be prone to believe. Just my personal opinion though. This campaign to gather the scientific community together before using the product further appears to be the first move in the war for hearts & minds.
Thanks for the follow up but most people here never considered there to be a rumor to begin with. Hope this serves as a reminder that people with agendas can say whatever they want but it is those who eat it up and fight to give it credibility by expressing their own uncertainty that cause the unnecessary headache.
The same is going on with ecover right now. Etc group has an agenda. Nyt, jim thomas, and maxx keep the uncertainty alive through their reporting (for or against), and ecover takes a pause for no reason. It's best to just not be part of the problem by pretending it's more than it is...
Imagine if the navy chose regi and szym again... it's a pr dream for navy to show tangible progress on cost. The public will like it too when costs fall from 26 to like 5. That's a win for the whole industry.
That's a natural assumption so I won't knock ya but I do think a fuels win isn't a terrible thing at this point. It will only utilize a fraction of the capacity and it keeps the progress on fuels going. Mkt development takes years to unfold and it's not easy to start up again once you put things on pause. I welcome a fuels win even if it means a setback to profitability and as long as its only a fraction of the capacity.
If anyone is foolish enough to think chatsko is for us... one sure has to wonder why it is so easy for the enemy to quote him to support his argument.
Us pat no. 8772575. (Issued today) "Nucleic acids useful in the manufacture of oil"
US pat no. 8765424. (Issued July 1) "Tailored oils produced from recombinant heterotrophic microorganisms"
I believe there are now 28 issued us patents and around 100 us applications under review. Many more international filings.
She even got a small word in with the company. Nice to see they stand by the claim.
Silence from the company must mean it's true. Otherwise they'd have issued a pr to make sure that 99% of the investors who never heard of the made up rumor are now in the loop...!
You mean issue a pr that puts petty investor concerns over lies made up by a greedy short to rest? You know how many meaningless pr's you'd have to issue after every false claim thereafter? Acknowledge investment risk and deal with your own uncertainty.
Maxx it out to make a name for himself. As long as he keeps throwing out the term synthetic biology with his sensational writing, his position as the editor of synbiobeta makes more sense. It doesn't matter if its good or bad pr for syn bio, he just wants to advance his career by becoming something. I find it disturbing how there are a few people (even here) who have eaten it up all along the way and have been supporting his self-centered reporting.
Not quite off topic, it's not exactly like Dana Perls just snuck into the synbiobeta meeting now quoted by the NYT article. (goo DOTgl/sRv6I5). Maxx is getting credit by a few people who believe he did a service by warning of the NYT article.... little do they know it was his him & his organization that helped play a part in making it happen through their carelessness.
It's annoying to keep hearing Maxx try to make this a headline issue, but in reality it's not. Those who keep getting excited over it because he keeps bringing it up only further his cause.